Invesaro

Stocks IMCC Financial statements

Financial statements

IM Cannabis Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data IM Cannabis Corp. files with the SEC in its annual reports.

In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Revenue9.0715.934.154.348.85454.7
Cost of revenue4.767.0825.5433845.645
Gross profit3.9310.56.339.169.858.459.69
Research and development0.230.14
Operating income-10.3-8.25-23-30.8-12.8-10.2-11.6
Interest expense0.7120.50.671.973.674.773.5
Interest income3.650.2823.56.77.012.213.43
Pre-tax income-7.33-28.5-0.16-26.1-9.46-12.8-11.7
Income tax0.090.260.5-1.140.77-1.020.09
Income from continuing operations-28.7-0.66-24.9-10.2-11.8
Net income to minority interests-0.13-0.04-0.76-2.41-0.73-1.19-0.43
Net income-7.29-28.7-17.8-189-9.5-10.6-11.3
EBITDA-9.67-7.32-20.9-28
EPS, basic-3.54-11.40-18.36-157.83-4.45-4.51
EPS, diluted-3.54-11.40-40.20-161.88-4.45-4.51

Balance sheet

FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents13.98.8913.92.451.810.862.73
Short-term investments03.13
Receivables0.520.6914.53.324.835.424.32
Inventory5.428.3729.416.69.983.224.27
Total current assets24.327.181.232.724.323.422.7
Property, plant and equipment3.395.5330.35.225.063.733.71
Lease right-of-use assets1.020.9418.21.931.310.450.4
Goodwill0.30.31219.7710.16.681.89
Intangible assets0.891.0930.97.915.83.331.22
Total assets30.938.128760.748.839.231.7
Short-term debt09.59.2512.115.114.3
Total current liabilities2.616.2751.233.832.834.934
Lease liabilities0.890.8217.81.080.820.170.05
Total liabilities4.7925.582.436.935.13635.4
Total debt12.515.615.3
Retained earnings-4.27-33-50.7-240-249-259-270
Shareholders' equity24.711.120122.714.55.24-3.73
Minority interests1.451.513.711.15-0.77-2.10.12
Total equity26.112.620523.813.73.15-3.62
Total liabilities and equity30.938.128760.748.839.231.7

Cash flow statement

FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Net income-7.42-28.7-18.5-191-10.2-11.8-11.8
Depreciation and amortization0.60.932.132.82
Cash from operations-5.96-7.92-34.4-12.6-8.08-1.084.72
Capital expenditures-1.55-2.62-4.58-1.56-0.58-0.16-0.01
Cash from investing-3.78-4.08-9.01-1.53-1.18-0.47-0.53
Debt issued07.89.645.482.623.27
Debt repaid-0.9500-4.98-4.83-3.83-1.81
Stock issued15.6028.13.761.690.945.07
Cash from financing17.16.7448.74.769.423.831.15
Exchange rate effect-0.980.21-0.33-2.04-0.8-3.23-3.47
Net change in cash6.34-5.045.02-11.5-0.64-0.951.86
Free cash flow-7.51-10.5-39-14.2-8.66-1.234.7

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.

Profitability

MetricValueHow it is calculated
Gross margin17.7%Gross profit / revenue.
Operating margin-21.2%Operating income / revenue.
Pre-tax margin-21.3%Pre-tax income / revenue.
Net margin-20.7%Net income / revenue.
FCF margin8.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin8.6%Cash from operations / revenue.
Return on assets (ROA)-31.9%Net income / average total assets.
Return on invested capital (ROIC)-63.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue0.0%Capital expenditures / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y1.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y0.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y28.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y14.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y1.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-1.5%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-171.1%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-19.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-19.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-3.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.67xCurrent assets / current liabilities.
Quick ratio0.21x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.08x(Cash + short-term investments) / current liabilities.
Debt / assets48.1%Total debt / total assets.
Liabilities / assets111.4%Total liabilities / total assets.
Net debtCA$12.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-3.31xOperating income / interest expense.
Working capital-CA$11.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets9.8%(Goodwill + intangible assets) / total assets.
Tangible book value-CA$6.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.54xRevenue / average total assets.
Fixed asset turnover14.7xRevenue / average property, plant and equipment.
Inventory turnover12.0xCost of revenue / average inventory.
Days inventory30 days365 x average inventory / cost of revenue.
Receivables turnover11.2xRevenue / average receivables.
Days sales outstanding32 days365 x average receivables / revenue.
Capex / operating cash flow0.3%Capital expenditures / cash from operations, when that is positive.
What was IM Cannabis Corp.'s revenue in fiscal 2025?

IM Cannabis Corp. reported revenue of CA$54.7M for fiscal 2025, 1.3% higher than the year before.

Was IM Cannabis Corp. profitable in fiscal 2025?

No. It reported a net loss of CA$11.3M.

How much free cash flow did IM Cannabis Corp. generate in fiscal 2025?

Cash from operations of CA$4.7M minus capital expenditures of CA$13.0K left free cash flow of CA$4.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to IM Cannabis Corp.